PXA1, PXA2, PXA3, PXA4, PXA5, PXA6

The invention consists of low-passage cell lines generated from primary pancreatic cancers established as nude-mice xenografts, and subsequently passaged in vitro. Description (Set) Proposed Use (Set) Due to their low-passage, these cell lines are more representative of the alterations in the pancreatic cancer genome than existing commercial pancreatic cancer cell lines.

Inventor(s): Beachy, Philip A.

Type of Offer: Licensing



« More Medical Patents

---